ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Adolescent Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,589Medicare Part D Prescriptions Filled, Including Refills
$565K Total Retail Price of All Prescriptions
447 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
SIMVASTATIN 345 291
AMLODIPINE BESYLATE 271 177
ZOLPIDEM TARTRATE 264 162
RANITIDINE HCL 226 180
MELOXICAM 195 144
HYDROCHLOROTHIAZIDE 184 140
METFORMIN HCL 165 130
LOSARTAN-HYDROCHLOROTHIAZIDE 159 122
LEVOTHYROXINE SODIUM 152 112
ALENDRONATE SODIUM 149 130
HYDROCODONE-ACETAMINOPHEN 142 66 S3
BENAZEPRIL HCL 139 96
METOPROLOL SUCCINATE 139 110
FUROSEMIDE 136 111
CRESTOR 132 102
NEXIUM 132 91
ATORVASTATIN CALCIUM 131 102
OMEPRAZOLE 128 87
METOPROLOL TARTRATE 115 105
METFORMIN HCL ER 113 89
PRAVASTATIN SODIUM 107 78
LISINOPRIL 104 55
TAMSULOSIN HCL 95 66
FENOFIBRATE 92 71
TRAMADOL HCL 85 78
LOSARTAN POTASSIUM 83 74
LIDODERM 82 78
BENAZEPRIL-HYDROCHLOROTHIAZIDE 82 57
ATENOLOL 76 49
CITALOPRAM HBR 76 49
PATANOL 76 59
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 55
AMLODIPINE BESYLATE-BENAZEPRIL 75 65
PLAVIX 68 56
JANUVIA 66 45
DIOVAN 64 38
LOVASTATIN 64 45
GLIMEPIRIDE 64 58
PROAIR HFA 63 53
CARVEDILOL 63 50
CYCLOBENZAPRINE HCL 62 25 R
FLUTICASONE PROPIONATE 60 39
CELEBREX 60 41
SYNTHROID 59 41
DIOVAN HCT 58 44
GABAPENTIN 57 44
BENICAR HCT 55 45
ALLOPURINOL 54 31
ADVAIR DISKUS 52 50
TRIAMCINOLONE ACETONIDE 52 41
CLOPIDOGREL 50 45
PANTOPRAZOLE SODIUM 50 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.